The Sault Area Hospital is a medical facility in Sault Ste. Marie, Ontario.

There are 293 beds in Sault Area Hospital.

During the past decade, Sault Area Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sault Area Hospital" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Ottawa Hospital Research Institute" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Incyte Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sault Area Hospital" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Sault Area Hospital" are "Non-small Cell Lung Cancer" (2 trials), "Adenocarcinoma of the Colon" (1 trials), "Anemia" (1 trials), "Breast Cancer" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Sault Area Hospital" in a lesser frequency.

Most popular intervention types in "Sault Area Hospital" are "Drug" (12 trials), "Other" (2 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-Fluorouracil" (1 trials), "AG-013736" (1 trials), "Apixaban" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sault Area Hospital" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sault Area Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Sault Area Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sault Area Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Sault Area Hospital has several departments that took part in Clinical trials: "Algoma District Cancer Program" - 43 trials